Pre- and postoperative cytokine release after in vitro whole blood lipopolysaccharide stimulation and frequent toll-like receptor 4 polymorphisms

Shock

Volumn 25, Issue 2, 2006, Pages 123-128

  Kumpf, Oliver ^a   Hamann, Lutz ^b   Schlag, Peter M ^a   Schumann, Ralf R ^b  

^a Section of Pathology   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cytokine induction; Endotoxin; Postoperative sepsis; SNP; TLR4

Indexed keywords

AMINO ACID SUBSTITUTION; CELLS, CULTURED; CYTOKINES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; NEOPLASMS; POINT MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TOLL-LIKE RECEPTOR 4;

EID: 33646792250     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000190823.44030.e6     Document Type: Article

References (32)

1. Pessaux P, Msika S, Atalla D, Hay JM, Flamant Y: Risk factors for postoperative infectious complications in noncolorectal abdominal surgery: a multivariate analysis based on a prospective multicenter study of 4718 patients. Arch Surg 138:314-324, 2003.
2. Wallace WC, Cinat ME, Nastanski F, Gornick WB, Wilson SE: New epidemiology for postoperative nosocomial infections. Am Surg 66:874-878, 2000.
3. Cohen J, Cristofaro P, Carlet J, Opal S: New method of classifying infections in critically ill patients. Crit Care Med 32:1510-1526, 2004.
4. Beutler B: Innate immunity: an overview. Mol Immunol 40:845-859, 2004.
5. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085-2088, 1998.
6. Takeda K, Akira S: TLR signaling pathways. Semin Immunol 16:3-9, 2004.
7. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA: TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25:187-191, 2000.
8. Agnese DM, Calvano JE, Hahm SJ, Coyle SM, Corbett SA, Calvano SE, Lowry SF: Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 186:1522-1525, 2002.
9. Feterowski C, Emmanuilidis K, Miethke T, Gerauer K, Rump M, Ulm K, Holzmann B, Weighardt H: Effects of functional toll-like receptor-4 mutations on the immune response to human and experimental sepsis. Immunology 109:426-431, 2003.
10. Lorenz E, Mira JP, Frees KL, Schwartz DA: Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 162:1028-1032, 2002.
11. Hawn TR, Verbon A, Janer M, Zhao LP, Beutler B, Aderem A: Toll-like receptor 4 polymorphisms are associated with resistance to Legionnaires' disease. Proc Natl Acad Sci USA 102:2487-2489, 2005.
12. Heesen M, Bloemeke B, Kunz D: The cytokine synthesis by heterozygous carriers of the toll-like receptor 4 Asp299Gly polymorphism does not differ from that of wild type homozygotes. Eur Cytokine Netw 14:234-237, 2003.
13. von Aulock S, Schroder NW, Gueinzius K, Traub S, Hoffmann S, Graf K, Dimmeler S, Hartung T, Schumann RR, Hermann C: Heterozygous toll-like receptor 4 polymorphism does not influence lipopolysaccharide-induced cytokine release in human whole blood. J Infect Dis 188:938-943, 2003.
14. Haupt W, Riese J, Mehler C, Weber K, Zowe M, Hohenberger W: Monocyte function before and after surgical trauma. Dig Surg 15:102-104, 1998.
15. Ertel W, Kremer JP, Kenney J, Steckholzer U, Jarrar D, Trentz O, Schildberg FW: Down-regulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85:1341-1347, 1995.
16. Bone RC, Sibbald WJ, Sprung CL: The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 101:1481-1483, 1992.
17. Vincent JL, Moreno R, Takala J, Wilatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707-710, 1996.
18. Le Gall JR, Lemeshow S, Saulnier F: A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957-2963, 1993.
19. Hamann L, Hamprecht A, Gomma A, Schumann RR: Rapid and inexpensive real-time PCR for genotyping functional polymorphisms within the toll-like receptor -2, -4, and -9 genes. J Immunol Methods 285:281-291, 2004.
20. Schroder NW, Schumann RR: Single nucleotide polymorphisms of toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 5:156-164, 2005.
21. Beutler B: Inferences, questions and possibilities in toll-like receptor signalling. Nature 430:257-263, 2004.
22. Takeda K, Akira S: Microbial recognition by toll-like receptors. J Dermatol Sci 34:73-82, 2004.
23. Haga Y, Beppu T, Doi K, Nozawa F, Mugita N, Ikei S, Ogawa M: Systemic inflammatory response syndrome and organ dysfunction following gastrointestinal surgery. Crit Care Med 25:1994-2000, 1997.
24. Ordemann J, Jacobi CA, Schwenk W, Stosslein R, Muller JM: Cellular and humoral inflammatory response after laparoscopic and conventional colorectal resections. Surg Endosc 15:600-608, 2001.
25. Majetschak M, Flach R, Kreuzfelder E, Jennissen V, Heukamp T, Neudeck F, Schmit-Neuerburg KP, Obertacke U, Schade FU: The extent of traumatic damage determines a graded depression of the endotoxin responsiveness of peripheral blood mononuclear cells from patients with blunt injuries. Crit Care Med 27:313-318, 1999.
26. Erridge C, Stewart J, Poxton IR: Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling. J Exp Med 197:1787-1791, 2003.
27. Schippers EF, van't Veer C, van Voorden S, Martin CA, le Cessie S, van Dissel JT: TNF-α promoter, Nod2 and toll-like receptor-4 polymorphisms and the in vivo and ex vivo response to endotoxin. Cytokine 26:16-24, 2004.
28. Armstrong L, Medford AR, Hunter KJ, Uppington KM, Millar AB: Differential expression of toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis. Clin Exp Immunol 136:312-319, 2004.
29. Harter L, Mica L, Stocker R, Trentz O, Keel M: Increased expression of toll-like receptor-2 and -4 on leukocytes from patients with sepsis. Shock 22:403-409, 2004.
30. Kido N, Nakashima I, Kato N: Correlation between strong adjuvanticity of klebsiella O3 lipopolysaccharide and its ability to induce interleukin-1 secretion. Cell Immunol 85:477-486, 1984.
31. Kimura Y, Yaegashi Y, Sato N: Tumor necrosis factor-α production after esophageal cancer surgery: differences in the response to lipopolysaccharide stimulation among whole blood, pleural effusion cells, and bronchoalveolar lavage fluid cells. Surg Today 29:10-15, 1999.
32. Haupt W, Zirngibl H, Klein P, Riese J, Hohenberger W: Reduced TNF-α and IL-6 production in patients who mount a preoperative acute phase response. Langenbecks Arch Surg 383:71-74, 1998.